COVID-19 drug development
About COVID-19 drug development
Global research effort since early 2020 sought COVID-19 therapies. Hundreds of organizations developed drug candidates, with 419 in clinical trials by April 2021. The WHO's "SOLIDARITY Trial" tested existing antivirals. Expedited approvals aimed to shorten the typical 5+ year drug development timeline.
COVID-19 drug development is a Rare trading card in the Eureka Archives series on WikiTCG. This card is based on the Wikipedia article about COVID-19 drug development, which has 0 pageviews and is available in 29 languages. 115 players have collected this card.
Battle Stats
- Power: 4
- HP: 8
- Deck Cost: 3
- Affinities: Life, Unity
More from Eureka Archives
The Eureka Archives series features cards spanning breakthroughs, inventors, and the laws of nature. Browse all cards in the Eureka Archives series or open a free pack to start collecting.
Image: Alexey Solodovnikov (Idea, Producer, CG, Editor), Valeria Arkhipova (Scientific Сonsultant) -- CC BY-SA 4.0
